-

BioMed Realty Promotes Three Senior Leaders Supporting Long-Term Growth in Life Science and Technology Real Estate

SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (the “Company”), a Blackstone portfolio company and the largest private operator of real estate for the life science and technology industries, announced today the promotions of three senior officers:

  • Allyn Aguirre to Senior Vice President, Chief Accounting Officer;
  • Andrew Laing to Senior Vice President, Asset Management; and
  • Kevin Tremblay to Senior Vice President, Leasing, West Coast Markets.

“Allyn, Andrew and Kevin have each demonstrated deep expertise, long-standing commitment and strong leadership as they’ve taken on increasing levels of responsibility for over a decade supporting the Company’s growth into an industry leader,” said BioMed Realty CEO Tim Schoen. “Their contributions across our commercial, corporate, and asset management capabilities are integral to our ability to deliver reliable, high-performing environments that support our tenants’ innovation and long-term success.”

  • Allyn Aguirre is now Senior Vice President, Chief Accounting Officer, after previously serving as Senior Vice President, Accounting and Treasury. In this role, Ms. Aguirre will oversee the Company’s accounting, treasury, and financial reporting functions. She joined BioMed Realty in 2011 and has supported the Company’s growth through acquisitions, development, and capital markets transactions.
  • Andrew Laing is now Senior Vice President, Asset Management, after previously serving as Vice President, Asset Management. Since joining BioMed Realty in 2012, Mr. Laing has strengthened the Company’s asset management and investment capabilities, while assuming increasing leadership responsibilities across the portfolio.
  • Kevin Tremblay is now Senior Vice President, Leasing, West Coast Markets, after previously serving as Senior Vice President, Leasing, California Markets. He joined the Company in 2013 and has played a key role in advancing BioMed Realty’s leasing strategy, initially in San Diego and now across four West Coast markets. In his expanded role, Mr. Tremblay will lead leasing activities throughout San Diego, the Bay Area, Seattle, and Boulder, representing more than 9 million square feet of operating assets.

“Allyn, Andrew and Kevin exemplify our collaborative, capable, and accountable culture, and in their expanded roles they will have an increasing impact on our clients, investment performance and financial results of the Company,” Schoen added. “It’s rewarding to see our senior leaders continue to grow and expand their careers, and these promotions reflect BioMed Realty’s continued investment in developing exceptional leaders across our organization.”

About BioMed Realty

BioMed Realty is the largest privately owned operator of real estate for the life science and technology industries in the United States and United Kingdom. The Company operates 17.3 million square feet of purpose-built laboratory and office space across the world’s top innovation hubs, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder, and Cambridge, U.K. With an additional 1.5 million square feet of Class A properties under development, BioMed Realty delivers flexible, reliable, and sustainable environments designed to accelerate discovery and keep world-changing work moving. Backed by more than 20 years of experience and the strength of being a Blackstone Real Estate portfolio company, BioMed Realty provides the confidence and partnership that fuel life-enhancing and world-changing innovation. To learn more, visit www.biomedrealty.com.

Contacts

Media Contact:
Ivan Alber, Director of Corporate Communications, BioMed Realty
619-840-2181
ivan.alber@biomedrealty.com

BioMed Realty


Release Versions

Contacts

Media Contact:
Ivan Alber, Director of Corporate Communications, BioMed Realty
619-840-2181
ivan.alber@biomedrealty.com

More News From BioMed Realty

BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park

SAN DIEGO & SOMERVILLE, Mass.--(BUSINESS WIRE)--BioMed Realty, the largest privately-owned operator of real estate for the life science and technology industries, and TransMedics Group, Inc. (“TransMedics”, ticker: TMDX), a publicly traded medical technology company transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that TransMedics has entered into a full building, 498,000-square-foot lease at Assembly Innovation Park, a premier life sci...

BioMed Realty’s Sustainability Report Emphasizes Long-Term Commitment to Sustainable, Innovative Environments as Recognized by GRESB

SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (“Company”), the largest privately owned operator of real estate for the life science and technology industries in the United States and the United Kingdom, today released its 2024 Sustainability Report, demonstrating continued industry leadership in sustainable development, decarbonization, community partnership, and responsible business operations. The report showcases how BioMed Realty’s tenant-first and vertically integrated model consistently provi...

Community-Driven, Sustainable Development Project at 585 Kendall Reaches Major Construction Milestone

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BioMed Realty, a Blackstone portfolio company and the largest private operator of life science real estate, alongside Suffolk Construction, Takeda and Global Arts Live, today celebrated the steel topping off of 585 Kendall, marking the placement of the final beam at the highest point of the building. Designed by CBT Architects, 585 Kendall is a mixed-use lab/office building and performing arts center in the Canal District of Kendall Square. The event recognize...
Back to Newsroom